product summary
Loading...
company name :
DIMA Biotechnology
product type :
protein
product name :
Human CD123 Protein, hFc-His Tag
catalog :
PME100003
quantity :
10 μg, 100 μg
price :
60 USD, 358 USD
more info or order :
image
image 1 :
DIMA Biotechnology PME100003 image 1
Figure 1. Human CD123, hFc-His Tag on SDS-PAGE under reducing condition.
image 2 :
DIMA Biotechnology PME100003 image 2
Figure 2. ELISA plate pre-coated by 2 μg/ml (100 μl/well) Human CD123, hFc-His tagged protein (PME100003) can bind Anti-CD123 Neutralizing antibody (BME100003) in a linear range of 0.98-26.70 ng/ml.
product information
Catalog Number :
PME100003
Product Name :
Human CD123 Protein, hFc-His Tag
Product Type :
protein
Size :
10 μg, 100 μg
List Price :
60 USD, 358 USD
Product Description :
Recombinant human CD123 protein with C-terminal human Fc and 6×His tag
Background :
Interleukin 3 receptor alpha (low affinity) (IL3RA), also known as CD123 (Cluster of Differentiation 123) is a 70-kD glycoprotein member of the hematopoietin receptor superfamily. This protein associates with a beta subunit common to the receptors for IL-5 and granulocyte-macrophage colony-stimulating factor (GM-CSF) to form a high-affinity receptor for IL-3. The interleukin-3 receptor α chain (CD123) has been identified as a potential immunotherapeutic target because it is overexpressed in AML compared with normal hematopoietic stem cells.
Purity :
The purity of the protein is greater than 95% as determined by SDS-PAGE and Coomassie blue staining.
Buffer :
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 23 % trehalose is added as protectants before lyophilization.
Uses :
Research use only
Application Summary :
Immunogen,WB,Elisa
Storage :
Store at -80°C for 12 months (Avoid repeated freezing and thawing)
more info or order :
company information
DIMA Biotechnology
Wuhan institute of Biotechnology B7
Biolake No.666 Gaoxin Road
Wuhan, Hubei
info@dimabio.com
https://www.dimabio.com
0118615307149771
headquarters: China
DIMA BIOTECH LTD (DIMABIO) focuses exclusively on the pre-clinical research market of Immune Oncology. Currently, we offer functional proteins and recombinant monoclonal antibodies. Our proprietary DimAb™ technology platform can directly clone IgG gene from immunized animal, which is a technology breakthrough in monoclonal antibody development.

All DIMABIOs protein products were manufactured by using mammalian cell expression system. To analyze the function of DIMABIOs proteins, we evaluated them by paired binding test between native ligand-receptor and or the binding capacity to the therapeutic antibodies. For DimAb™ recombinant monoclonal antibodies, we focus mainly on identifying clones with flow and blocking activity.